Course, patterns, and risk-factors for chemotherapy-induced emesis in cisplatin-pretreated patients: a study with ondansetron

On the receiving end—patient perception of the side-effects of cancer chemotherapy

Alan S. Coates, Suzanne Abraham, S.B. Kaye et al. · European Journal of Cancer and Clinical Oncology · 1983 · 1K citations

Palliative Care, Medicine, Cancer Management +8

Antiemetic Efficacy of High-Dose Metoclopramide: Randomized Trials with Placebo and Prochlorperazine in Patients with Chemotherapy-Induced Nausea and Vomiting

Richard J. Gralla, Loretta M. Itri, Sharon E. Pisko et al. · New England Journal of Medicine · 1981 · 709 citations

Therapeutic Drug Monitoring, Advanced Cancer, Oncology +14

Efficacy of Ondansetron (Gr 38032F) and the Role of Serotonin in Cisplatin-Induced Nausea and Vomiting

Luigi X. Cubeddu, Irene Hoffmann, Nery Fuenmayor et al. · New England Journal of Medicine · 1990 · 413 citations · Full text

Comparison of the 5-Hydroxytryptamine₃(Serotonin) Antagonist Ondansetron (Gr 38032F) with High-Dose Metoclopramide in the Control of Cisplatin-Induced Emesis

Michel Marty, P Pouillart, Jean Pierre Droz et al. · New England Journal of Medicine · 1990 · 411 citations

Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin.

Mark G. Kris, Richard J. Gralla, R A Clark et al. · Journal of Clinical Oncology · 1985 · 341 citations

Cisplatin Administration, High-dose Cisplatin, Medicine +9